Literature DB >> 935167

Practolol-induced SLE-like syndrome.

M W Stewart, S W Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 935167      PMCID： PMC1864107     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  9 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

Review 6.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616

7.  Letter: Sclerosing peritonitis and practolol.

Authors:  Y S Fan; J R Condon; P L Brooks; J Rhodes; H Dexter; V Robinson
Journal:  Lancet       Date:  1975-03-15       Impact factor: 79.321

8.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

9.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
  9 in total
  1 in total

1.  Sclerosing peritonitis due to practolol.

Authors:  R P Thompson; B T Jackson
Journal:  Br Med J       Date:  1977-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.